Milestone Pharma Files Q1 2025 10-Q
Ticker: MIST · Form: 10-Q · Filed: May 14, 2025 · CIK: 1408443
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
TL;DR
Milestone Pharma's Q1 2025 10-Q is in. Financials updated.
AI Summary
Milestone Pharmaceuticals Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information, including common stock and additional paid-in capital as of March 31, 2025, and compares it to previous periods. The company is based in Montreal and operates in the pharmaceutical preparations industry.
Why It Matters
This filing provides investors with the latest financial snapshot of Milestone Pharmaceuticals, crucial for understanding the company's financial health and performance in the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags or significant new risks highlighted.
Key Numbers
- 20250331 — Reporting Period End Date (Indicates the financial data covers up to this date.)
- 20250514 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Milestone Pharmaceuticals Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- MONTREAL (location) — Company's business and mailing address
- PHARMACEUTICAL PREPARATIONS [2834] (industry) — Company's Standard Industrial Classification
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 14, 2025.
What is Milestone Pharmaceuticals Inc.'s primary industry?
Milestone Pharmaceuticals Inc. is in the Pharmaceutical Preparations industry, with SIC code 2834.
Where is Milestone Pharmaceuticals Inc. located?
Milestone Pharmaceuticals Inc. is located in Montreal.
What specific financial items are mentioned in relation to March 31, 2025?
The filing mentions common stock and additional paid-in capital as of March 31, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Milestone Pharmaceuticals Inc. (MIST).